静脉泵入胺碘酮导致静脉炎的护理干预  

Nursing interventions on peripheral phlebitis caused by the intravenous infusion of amiodarone

作　　者：韩梅[1] 祝鹏举[1] 

机构地区：[1]山东省千佛山医院,山东济南250014

出　　处：《医学检验与临床》2017年第1期31-32,53,共3页Medical Laboratory Science and Clinics

基　　金：山东省医药卫生科技发展计划（2016WSB04044）

摘　　要：目的：探讨患者静脉泵入胺碘酮导致外周静脉炎的护理干预措施。方法：50例需接受胺碘酮治疗的患者分为对照组和试验组两组，对照组按常规的方法静脉泵入胺碘酮，试验组选择粗直大静脉血管，间隔24小时后更换留置针管路，如发现静脉炎可提早更换；试验组胺碘酮浓度较对照组浓度减半、泵入速度增加一倍；两组均给予5%葡萄糖液25～40滴/分静滴维持静脉通道，根据患者的心功能情况调整滴速，留置针穿刺近端均给予美皮康保护。观察并比较两组静脉炎发生情况。结果：试验组外周静脉炎发生率较对照组显著减少，静脉炎程度也减轻。结论：选择粗直大静脉血管，每天更换静脉留置针通道，泵入的胺碘酮浓度减半、速度增倍，可显著减少、减轻外周静脉炎的发生。Objective：This study was designed to investigate the nursing interventions on peripheral phlebitis caused by the intra-venous infusion of amiodarone.Methods： 50 patients with amiodarone therapy were divided into control and experimental groups randomly. Amiodarone was infused intravenously by the conventional method in the control group. In experimental group, the larger blood vessels were chosen. The venous access was replaced every 24 hours, while the venous access would be replaced in advance once vein phlebitis occurred. The concentration of Amiodarone was decreased by half in the experimental group, compared with in the control group, while the pump speed was increased doubly in the experiment group. All the patients in both groups were given intravenous infusion of 5%glucose solution which maintained 20 to 30 drops per minute. The speed was adjusted by the cardiac func-tion of patients. The proximal trocar was protected by thin dressing. The incidence of phlebitis was observed. Results：The incidence of peripheral vein inflammation was significantly reduced in the experimental group compared with in the control group, and the de-gree of phlebitis was reduced as well. Conclusion： The choice of larger blood vessels, replacement of intravenous tubing daily, the concentration reduction of amiodarone by half and the double acceleration of the speed could significantly reduce the incidence of pe-ripheral vein inflammation.

关 键 词：胺碘酮 静脉炎 护理干预 

分 类 号：R543.6[医药卫生—心血管疾病]